PMID- 10627605 OWN - NLM STAT- MEDLINE DCOM- 20000127 LR - 20191023 IS - 1529-2401 (Electronic) IS - 0270-6474 (Print) IS - 0270-6474 (Linking) VI - 20 IP - 1 DP - 2000 Jan 1 TI - Evidence that brain-derived neurotrophic factor from presynaptic nerve terminals regulates the phenotype of calbindin-containing neurons in the lateral septum. PG - 274-82 AB - Brain-derived neurotrophic factor (BDNF) is transported anterogradely in neurons of the CNS and can be released by activity-dependent mechanisms to regulate synaptic plasticity. However, few neural networks have been identified in which the production, transport, and effects of BDNF on postsynaptic neurons can be analyzed in detail. In this study, we have identified such a network. BDNF has been colocalized by immunocytochemistry with tyrosine hydroxylase (TH) in nerve fibers and nerve terminals within the lateral septum of rats. BDNF-containing nerve fibers terminate on a population of calbindin-containing neurons in lateral septum that contain TrkB, the high-affinity receptor for BDNF. Overexpression of BDNF in noradrenergic neurons increased levels of calbindin in septum, as well as in whole-brain lysates. Septal levels of calbindin and BDNF partially decreased after unilateral lesions of the medial forebrain bundle (MFB), induced with 6-hydroxydopamine, a treatment that abolished TH staining. These data suggest that BDNF is anterogradely transported within the MFB in catecholaminergic neurons arising from brainstem nuclei. To determine whether BDNF affects the production of calbindin in lateral septal neurons directly, we tested the effects of BDNF on cultures of septal neurons from embryonic day 16-17 rats. BDNF promoted the expression of calbindin, as well as the arborization of calbindin-containing neurons, but BDNF had no effect on cell division or survival. Together, these results suggest that BDNF, anterogradely transported in catecholaminergic neurons, regulates calbindin expression within the lateral septum. FAU - Fawcett, J P AU - Fawcett JP AD - Center for Neuronal Survival and Division of Neurosurgery, and Montreal Neurological Institute and the Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada H3A 2B4. FAU - Alonso-Vanegas, M A AU - Alonso-Vanegas MA FAU - Morris, S J AU - Morris SJ FAU - Miller, F D AU - Miller FD FAU - Sadikot, A F AU - Sadikot AF FAU - Murphy, R A AU - Murphy RA LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - J Neurosci JT - The Journal of neuroscience : the official journal of the Society for Neuroscience JID - 8102140 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Calbindins) RN - 0 (S100 Calcium Binding Protein G) RN - 0 (Sympatholytics) RN - 8HW4YBZ748 (Oxidopamine) RN - EC 1.14.16.2 (Tyrosine 3-Monooxygenase) RN - EC 1.14.17.1 (Dopamine beta-Hydroxylase) RN - X4W3ENH1CV (Norepinephrine) SB - IM MH - Age Factors MH - Animals MH - Axonal Transport/physiology MH - Brain-Derived Neurotrophic Factor/analysis/*genetics/metabolism MH - Calbindins MH - Cells, Cultured MH - Dopamine beta-Hydroxylase/genetics MH - Female MH - Gene Expression Regulation, Enzymologic MH - Mice MH - Mice, Transgenic MH - Nerve Fibers/chemistry/enzymology MH - Neurons/*chemistry/enzymology/ultrastructure MH - Norepinephrine/physiology MH - Oxidopamine MH - Phenotype MH - Pregnancy MH - Presynaptic Terminals/*chemistry MH - Promoter Regions, Genetic/physiology MH - Rats MH - Rats, Sprague-Dawley MH - S100 Calcium Binding Protein G/*analysis MH - Septal Nuclei/*cytology MH - Sympatholytics MH - Tyrosine 3-Monooxygenase/analysis PMC - PMC6774122 EDAT- 2000/01/11 00:00 MHDA- 2000/01/11 00:01 PMCR- 2000/07/01 CRDT- 2000/01/11 00:00 PHST- 2000/01/11 00:00 [pubmed] PHST- 2000/01/11 00:01 [medline] PHST- 2000/01/11 00:00 [entrez] PHST- 2000/07/01 00:00 [pmc-release] AID - 3801 [pii] AID - 10.1523/JNEUROSCI.20-01-00274.2000 [doi] PST - ppublish SO - J Neurosci. 2000 Jan 1;20(1):274-82. doi: 10.1523/JNEUROSCI.20-01-00274.2000.